ASP Isotopes bets big on SA as critical minerals and nuclear demand surge

Loading player...
ASP Isotopes CEO Paul Mann explains why the group is doubling down on South Africa — from turning around the Renergen gas asset to building a global isotope business spanning nuclear medicine, semiconductors and clean energy, backed by a strong balance sheet and US government support.
2 Feb 7AM English South Africa Investing · Business News

Other recent episodes

Solly Moeng on Ramaphosa, his shadowy advisers and a fading legacy

In their weekly chat Chris Steyn and political commentator Solly Moeng dissect President Cyril Ramaphosa’s tough week on several fronts: The Madlanga Commission of Inquiry is seeking answers from his very influential former adviser, Dr Bejani Chauke, particularly in relation to WhatsApp chats with a notorious late taxi boss; his…
29 Oct 10AM 21 min

Gareth van Onselen on the metro races that could redraw SA politics

Six days before the vote, four serious pollsters could not agree on who was winning Johannesburg. Gareth van Onselen, whose Victory Research polls have drawn fire from the ANC and ActionSA alike, told Alec Hogg why the metro numbers diverged, why turnout could swing a party by up to five…
29 Oct 8AM 44 min

Donald MacKay: Find the JSE guilty - or not - and move on

In this interview with Chris Steyn, Donald MacKay, the CEO of XA Global Trade Advisors, describes how anti-competitive behaviour is rewarded when investigations drag on. He was speaking out amid a long wait to find out whether the Johannesburg Stock Exchange (JSE) will be hit with a penalty of ten…
29 Oct 5AM 10 min